跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,371 条关于
“cardiovascular hospitalization”
全部
13,371
临床试验
9,812
药物
91
机构
105
资讯
3,363
去年
Abbott's FreeStyle Libre CGM System Reduces Cardiovascular Hospitalization Risk in Diabetes Patients
去年
FDA Approves Attruby (Acoramidis) for ATTR-CM, Reducing Cardiovascular Death and Hospitalization
去年
FDA Approves BridgeBio's Attruby for ATTR-CM, Reducing Cardiovascular Death and Hospitalization
去年
Acoramidis Approved for ATTR-CM, Showing Sustained Benefits in Long-Term Study
17年前
FDA Approves Sanofi's Multaq for Atrial Fibrillation Patients, Marking First New Treatment in Two Decades
去年
FDA Approves Attruby (Acoramidis) for ATTR-CM, Showing Rapid Reduction in Cardiovascular Events
2年前
ABYSS Trial: No Significant Difference in Outcomes Between Continuing or Stopping Beta-Blockers Post-MI
去年
BridgeBio's Attruby (acoramidis) Approved by FDA for ATTR-CM Treatment
去年
FDA Approves BridgeBio's Attruby (acoramidis) for ATTR-CM
去年
Acoramidis Shows Sustained Mortality Benefit in ATTR-CM Patients After 42 Months
第 1 页，共 337 页
上一页
下一页
